Petros Pharmaceuticals, Inc.
PTPI
$0.0305
-$0.0011-3.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.63% | -317.59% | -235.45% | 69.39% | -779.67% |
| Total Depreciation and Amortization | -- | -13.15% | 1.80% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.60% | 5,233.82% | 90.31% | -245.98% | 119.61% |
| Change in Net Operating Assets | -107.38% | 169.93% | 395.66% | -1,779.52% | -99.05% |
| Cash from Operations | -271.96% | 225.18% | 53.61% | -46.49% | 49.79% |
| Capital Expenditure | -- | 71.73% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 71.73% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -1.50% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 52.09% | -51.38% | -40.76% | 43.90% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 860.64% | 58.75% | -41.70% | -74.63% | 52.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,915.32% | 94.82% | 1.53% | -60.47% | 51.30% |